Sana Biotechnology SANA Interest Income (Expense), Nonoperating
Interest Income (Expense), Nonoperating at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's interest income (expense), nonoperating.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's interest income (expense), nonoperating?
- Sana Biotechnology (SANA) reported interest income (expense), nonoperating of $951K in Q1 2026.
- How has Sana Biotechnology's interest income (expense), nonoperating changed year-over-year?
- Sana Biotechnology's interest income (expense), nonoperating decreased by 4.1% year-over-year, from $992K to $951K.
- What is the long-term trend for Sana Biotechnology's interest income (expense), nonoperating?
- Over 4 years (2021 to 2025), Sana Biotechnology's interest income (expense), nonoperating has grown at a 54.5% compound annual growth rate (CAGR), from $676K to $3.85M.